News from cormedix inc

Jun 23, 2014, 16:15 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix, Inc. Finalizes Pivotal Phase 3 Study Protocol for FDA

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

May 23, 2014, 16:15 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Notified of NYSE MKT Listing Deficiency

 CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...

May 13, 2014, 17:26 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. to Announce First Quarter 2014 Results on May 15, 2014

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic...

Apr 07, 2014, 08:30 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. Welcomes Additional Board Members

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Mar 27, 2014, 18:39 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. to Report 2013 Year End Results on March 31, 2014, and Host Conference Call at 9 am on April 1, 2014

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic products for...

Mar 10, 2014, 16:05 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. Announces Close of Registered Direct Offering

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Mar 04, 2014, 21:50 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. Announces Registered Direct Offering

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Jan 13, 2014, 08:30 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Expands Neutrolin® Sales with Middle East Distribution Agreements

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...

Jan 10, 2014, 08:32 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Awarded European Patent for Neutrolin

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...

Jan 08, 2014, 09:16 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. to Raise $2,000,000 in Follow On Offering

- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Dec 23, 2013, 09:51 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Receives Minutes from Neutrolin Pre-IND Meeting with FDA

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Dec 12, 2013, 11:14 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Announces First Sales of Neutrolin® in the European Union

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...

Nov 15, 2013, 11:43 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix to Report Third Quarter Financial Results on November 19, 2013

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Oct 23, 2013, 09:00 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. Closes $3,000,000 Preferred Stock Offerings

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Oct 18, 2013, 10:09 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. to Raise $3,000,000 in Concurrent Offerings

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...

Sep 05, 2013, 07:00 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Reports Receipt of European Patent Office Decision to Allow Prosl Patent to Proceed in European Union

 CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...

Aug 14, 2013, 18:48 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Reports Second Quarter 2013 Results

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...

Jul 15, 2013, 15:30 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Granted Extension of NYSE MKT Listing

 CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge